Page 1231 - Cote clinical veterinary advisor dogs and cats 4th
P. 1231

616   Malassezia Dermatitis


           •  CBC, serum chemistry panel, and urinalysis   for 2 consecutive days per week or given   numbers disproportionate to the level of
                                                                                   pruritus experienced by the animal.
            to screen for systemic internal diseases  daily for cycles of 1 week on/1 to 4 weeks   •  Skin  culture  for  Malassezia yeast is not
  VetBooks.ir  •  Feline retroviral testing   Drug Interactions                    recommended in clinical practice because
                                                off after the initial induction dose (see Acute
           •  Hormonal testing (e.g., screening tests for
                                                General Treatment above).
            endocrinopathies)
                                                                                   these organisms are residents on the skin.
                                                                                   considered superior to cytologic evaluation
            TREATMENT                         Azole therapy may alter the metabolism or   •  Biopsy with histopathologic evaluation is not
                                              distribution of other prescribed medication   for the diagnosis of  Malassezia dermatitis
           Treatment Overview                 by inhibiting cytochrome P450 metabolizing   (most of the surface scale is lost during biopsy
           The main goal is to reduce pruritus and remove   enzymes and P-glycoprotein transporting   processing) but may be useful in the diagnosis
           seborrhea. This is accomplished by killing yeast   pumps.  Terbinafine does not inhibit these   of primary skin disorders in which Malassezia
           and controlling underlying primary diseases   enzymes. Specifically, azoles cannot be given   dermatitis is a secondary phenomenon.
           and risk factors.                  with high-dose, extralabel macrocyclic lactones   •  Do not use selenium sulfide on cats; it is
                                              (e.g., avermectins); if needed, dosage reduction   too irritating to their skin.
           Acute General Treatment            and close monitoring are required.  •  Enilconazole is not approved for small-animal
           •  Keratomodulating (antiseborrheic) and anti-                          use in some countries.
            yeast topical therapies (e.g., sulfur/salicylic   Possible Complications  •  When given in tablet or capsule form, the
            acid, phytosphingosine, ceramides, benzoyl   •  Idiosyncratic cutaneous adverse reactions to   azole drugs ketoconazole and itraconazole are
            peroxide, selenium sulfide, boric/acetic   topical therapies           best absorbed systemically if administered
            acid, miconazole, clotrimazole, climbazole,   •  Patient  may  have  adverse  reactions  (e.g.,   with food; failure to do so may reduce
            ketoconazole, terbinafine, enilconazole, lime   vomiting, diarrhea, hepatotoxicosis, vasculitis,   bioavailability of these drugs by up to 40%.
            sulfur, chlorhexidine) can be applied daily to   lightening of haircoat, pruritus) to systemic   •  When not contraindicated, most allergic dogs
            weekly, depending on the formulation used   azoles.                    benefit from a short course of antipruritic/
            (e.g., shampoo, solution, lotion, spray, wipe,   •  Ketoconazole may inhibit cortisol synthesis   antiinflammatory therapy (e.g., glucocor-
            mousse).                            at dosages greater than 10 mg/kg/day.  ticoid, oclacitinib, lokivetmab) during the
           •  Systemic antifungal therapy may be warranted                         initiation of other antiyeast measures (p. 91).
            for severe infections or those not respond-  Recommended Monitoring
            ing to topical therapy alone. Duration of   •  Clinical signs and cytologic evaluation every   Prevention
            systemic therapy should persist beyond (e.g.,   3-4 weeks during therapy  Correctly  identifying and treating  for all
            1-2 weeks) clinical and cytologic resolution   •  Other monitoring recommendations are at   underlying  predisposing  factors  favorable  to
            (usually a minimum of 3-4 weeks). Griseoful-  the discretion of the clinician and based on   yeast overgrowth
            vin has no effect against Malassezia species,   underlying predisposing diseases.
            and terbinafine may not be as effective as                           Technician Tips
            azoles.                            PROGNOSIS & OUTCOME               Technicians managing patients with Malassezia
            ○   Ketoconazole 5-10 mg/kg PO q 24h with                            dermatitis should be proficient in collection and
              food; other azoles better suited for cats,   •  Failure  to  detect  and  treat  underlying   exam of cytologic skin samples (p. 1091) and
              or                                disease(s) will result in partial treatment   capable of instructing owners on appropriate
            ○   Itraconazole 5-10 mg/kg PO q 24h with   success, treatment failure, or relapse.  use of topical therapy.
              (capsules) or without (suspension) food,   •  For incurable diseases (e.g., primary corni-
              or                                fication disorders), therapy for  Malassezia   Client Education
            ○   Fluconazole 2.5-5 mg/kg PO q 24h, or  dermatitis is often lifelong.  •  The identification of Malassezia dermatitis is
            ○   Terbinafine  30  mg/kg  PO  q  24h  with                           only the beginning of the diagnostic process
              food                             PEARLS & CONSIDERATIONS             because yeast overgrowth is secondary to
           •  Because  ≈40%  of  dogs  with  Malassezia                            another condition.
            dermatitis have concurrent superficial staphy-  Comments             •  Show clients how to effectively use topical
            lococcal pyoderma, treating any associated   •  Malassezia dermatitis is one of the most   antiyeast treatments.
            bacterial infection with oral antibiotics at an   overlooked causes of pruritus in the dog.
            appropriate dose and duration (minimum 3   •  Malassezia dermatitis tends to occur in body   SUGGESTED READING
            weeks) can help improve cutaneous signs.  areas rich in sebaceous glands and high in   Negre A, et al: Evidence-based veterinary dermatology:
                                                relative humidity, and it is commonly associ-  a systematic review of interventions for Malassezia
           Chronic Treatment                    ated with allergic dermatitis.     dermatitis in dogs. Vet Dermatol 20:1-12, 2008.
           •  Therapy for underlying predisposing diseases  •  How many yeasts are cytologically significant?   AUTHOR: Adam P. Patterson, DVM, DACVD
           •  Topical keratomodulating and/or antiyeast   Finding any yeast from typical clinical   EDITOR: Manon Paradis, DMV, MVSc, DACVD
            therapy at reduced frequencies of application   lesions is significant. However, because false-
            if possible                         negatives are possible with cytology, typical
           •  Pulse  therapy  with  a  systemic  azole  or   signs and pruritic distribution pattern (body
            terbinafine can be used for remitting and   folds) should not be taken lightly when
            relapsing episodes of Malassezia dermatitis   making a diagnosis.
            because these drugs concentrate in the skin.   •  Dogs with atopic dermatitis may be hyper-
            Typically, the same initial dosage is prescribed   sensitive to  Malassezia, resulting in yeast











                                                     www.ExpertConsult.com
   1226   1227   1228   1229   1230   1231   1232   1233   1234   1235   1236